What public policies have been more effective in promoting rational prescription of drugs?

Journal of Epidemiology and Community Health

Volumn 65, Issue 5, 2011, Pages 387-388

  Diogène, Eduard ^a,b,c   Figueras, Albert ^a,b  

^a Fundacion Institut Catala de Farmacologia   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

CLINICAL PRACTICE; DECISION MAKING; EDITORIAL; HEALTH CARE POLICY; HUMAN; LEGAL ASPECT; POLICY; STATISTICS; UNITED STATES;

DECISION MAKING; HEALTH POLICY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; PUBLIC POLICY; UNITED STATES;

EID: 79955524937     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.101311     Document Type: Editorial

References (12)

1. Morgan SG, Bassett KL, Wright JM, et al. "Breakthrough" drugs and growth in expenditure on prescription drugs in Canada. BMJ 2005;331:815-16.
2. WHO. Guide to good prescribing. A practical manual. Geneva: World Health Organization, WHO/DAP/94.11, 1994.
3. WHO. Report of the Conference of Experts, Nairobi, 1985. Geneva: World Health Organization, 1987.
4. Wettermark B, Godman B, Jacobsson B, et al. Soft regulations in pharmaceutical policy making. Appl Health Econ Health Policy 2009;7:137-47.
5. Garattini S, Bertele V, Godman B, et al. Enhancing the rational use of new medicines across European health care systems. A position paper. Eur J Clin Pharmacol 2008;64:1137-8.
6. Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med 2010;7:e1000326.
7. Pearson SA, Ross-Degnan D, Payson A, et al. Changing medication use in managed care: a critical review of the available evidence. Am J Manag Care 2003;9:715-31.
8. Lu CY, Ross-Degnan D, Soumerai SB, et al. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literatured2001-2007. BMC Health Serv Res 2008;8:75.
9. Aaserud M, Austvoll-Dahlgren A, Sturm H, et al. Pharmaceutical policies: effects on rational drug use, an overview of 13 reviews (Protocol). Cochrane Database Syst Rev 2006;(2):CD004397. doi:10.1002/ 14651858.CD004397.pub2.
10. Gabbay J, le May A. Evidence based guidelines or collectively constructed "mindlines" ? Ethnographic study of knowledge management in primary care. BMJ 2004;329:1013.
11. Garattini S, Bertelé V. Europe's opportunity to open up drug regulation. BMJ 2010;340:842-3.
12. Garattini S, Chalmers I. Patients and the public deserve big changes in evaluation of drugs. BMJ 2009;338:804-6.